Substituted N-acetyl-L-cysteine derivatives and related compounds
US9630937B2 · kind B2 · utility
3Cited by
14References
60Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 7, 2014 |
| Grant date | Apr 25, 2017 |
| Priority date | — |
| Expiry date | Nov 7, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/513
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel substituted N-acetyl-L-cysteine (NAC) derivatives and related compounds and methods of using these compounds for the treatment of diseases and/or conditions, including but not limited to diseases and/or conditions of, or involving, the Central Nervous System (CNS), including schizophrenia adrenoleukodystrophy, mitochondrial diseases (e.g. Leigh syndrome, Alpers' disease, and MELAS), Huntington's disease, trichotillomania, HIV-associated neurocognitive disorder, hypoxic-ischemic encephalopathy, drug craving, and drug addiction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.